Based on the flanking region approach to copy number alteration estimation, the mean percent of the genome gained and lost was calculated for each of the tumor subgroups (e.g., estrogen receptor positive versus negative) and differences evaluated using the Wilcoxon rank sum test (Additional file 3). This evidence concerns the gene ESR1 and neoplasm.